Interferon-alpha: Clinical Trials

4 trials of Interferon-alpha, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 withdrawn, 1 completed. 4 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable4Withdrawn 3, Completed 1

Follow Interferon-alpha: new trials by email Literature Review of Interferon-alpha trials Research Report on Interferon-alpha

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of High-dose Vitamin C Combined With Chinese Medicine Against Coronavirus Pneumonia (COVID-19)
Alpha-interferon alpha, abidol, ribavirin, Buzhong Yiqi plus and minus formula, Huhuang Detoxicity Paste, Baimu Qingre Jiedu Paste, fumigation/inhalation of vitamin C, Alpha-interferon, abidol, ribavirin, Buzhong Yiqi plus and minus formula, Huhuang Detoxicity Paste, Baimu Qingre Jiedu Paste and 5% glucose, Alpha-interferon, abidol, ribavirin, Buzhong Yiqi plus and minus formula, Huhuang Detoxicity Paste, Baimu Qingre Jiedu Paste and high-dose vitamin C treatment - COVID-19
Not applicableCompletedXi'an International Medical Center Hospital302020-02-062023-09-21
Interferon-α Prevents Leukemia Relapse of AML Patients After Transplantation
Interferon-alpha - Interferon-A-2B, Relapse
Not applicableWithdrawnPeking University People's Hospital2017-05-012020-09-23
Inflammation, Stress & Social Behavior: Using Ecological Assessments & Model Systems to Enhance Relevance to Health Outcomes
Interferon-alpha - Hepatitis C
Not applicableWithdrawnUniversity of Arizona2012-06-012013-07-22
The Efficiency of Postoperative Interferon-alpha Treatment in p48 Positive Patients With Hepatocellular Carcinoma
interferon-alpha - Hepatocellular Carcinoma
Not applicableWithdrawnFudan University2008-01-012012-08-23

Conditions studied

COVID-19 (1)  ·  Carcinoma, Hepatocellular (1)  ·  Hepatitis C (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Recurrence (1)  ·  Social Behavior (1)

Sponsors

Fudan University (1)  ·  Peking University People's Hospital (1)  ·  University of Arizona (1)  ·  Xi'an International Medical Center Hospital (1)

Countries

China (2)  ·  United States (1)

Top investigators

Charles L. Raison, MD (1)  ·  Guoyu Wang (1)  ·  Hui Gao (1)  ·  Hui-chuan Sun, MD (1)  ·  Jiayue Shan (1)  ·  Kuiwei Zhang (1)  ·  Lei Shang (1)  ·  Rui Wang (1)  ·  Shanjiao Jiang (1)  ·  Shenhao Liu (1)  ·  Xiaojun Huang, Dr. (1)  ·  Xijing He, MD (1)  ·  Xudong Yang (1)  ·  Yali Wang (1)  ·  Yifan Feng (1)

NIH funding

R01AT007297 (1)